Literature DB >> 32302663

Prediction of lymph node metastasis using semiquantitative evaluation of PET for lung adenocarcinoma.

Atsushi Kagimoto1, Yasuhiro Tsutani1, Yu Izaki1, Yoshinori Handa1, Takahiro Mimae1, Yoshihiro Miyata1, Morihito Okada2.   

Abstract

BACKGROUND: This study aimed to investigate the efficacy of the Deauville criteria, a 5-point semiquantitative scale criteria to assess the maximum standardized uptake value (SUVmax) of [18F]-fluoro-2-deoxy-D-glucose (FDG) on positron emission tomography (PET)/computed tomography (CT), in predicting lymph node metastasis and other pathological invasive characteristics of early-stage lung adenocarcinoma.
METHODS: In this retrospective study including 453 patients undergoing lobectomy or segmentectomy with lymph node dissection for clinical T1 or Tis N0 adenocarcinoma between April 2011 and March 2019, the FDG-PET/CT scans were evaluated using the Deauville criteria to analyze the relationship of Deauville score with the clinicopathological characteristics and prognosis.
RESULTS: The lymph node metastases were present in 0 (0%), 2 (1.1%), 6 (9.5%), 6 (15.8%), and 13 (15.7%) patients with Deauville scores of 1, 2, 3, 4 and 5, respectively. The pathological invasive characteristics (lymphatic, vascular, or visceral pleural invasion) were detected in 2 (2.4%), 17 (9.9%), 18 (28.6%), 23 (60.5%), and 54 (65.1%) patients with Deauville score 1, 2, 3, 4, and 5, respectively. The 3-year recurrence-free survival was longer in the patients with a Deauville score of 1-2 (97.2%) than those with a Deauville score of 3 (86.2%, p < 0.001) or 4-5 (80.7%, p < 0.001).
CONCLUSIONS: The 5-point-scale evaluation of the SUVmax on FDG-PET/CT using the Deauville score was useful in predicting not only lymph node metastasis but also other malignant features of early-stage lung adenocarcinoma.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Year:  2020        PMID: 32302663     DOI: 10.1016/j.athoracsur.2020.03.032

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma.

Authors:  Atsushi Kagimoto; Yasuhiro Tsutani; Yoshinori Handa; Takahiro Mimae; Yoshihiro Miyata; Morihito Okada
Journal:  Ann Surg Oncol       Date:  2020-09-18       Impact factor: 5.344

2.  Risk analysis in peripheral clinical T1 non-small cell lung cancer correlations between tumor-to-blood standardized uptake ratio on 18F-FDG PET-CT and primary tumor pathological invasiveness: a real-world observational study.

Authors:  Xiao-Feng Li; Yun-Mei Shi; Rong Niu; Xiao-Nan Shao; Jian-Feng Wang; Xiao-Liang Shao; Fei-Fei Zhang; Yue-Tao Wang
Journal:  Quant Imaging Med Surg       Date:  2022-01

3.  A Radiomic Approach to Access Tumor Immune Status by CD8+TRMs on Surgically Resected Non-Small-Cell Lung Cancer.

Authors:  Jie Min; Fei Dong; Pin Wu; Xiaopei Xu; Yimin Wu; Yanbin Tan; Fan Yang; Ying Chai
Journal:  Onco Targets Ther       Date:  2021-09-27       Impact factor: 4.147

4.  Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer.

Authors:  Atsushi Kagimoto; Yasuhiro Tsutani; Takahiro Mimae; Yoshihiro Miyata; Morihito Okada
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02

5.  Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer.

Authors:  Yasuhiro Tsutani; Yoshihisa Shimada; Hiroyuki Ito; Yoshihiro Miyata; Norihiko Ikeda; Haruhiko Nakayama; Morihito Okada
Journal:  Front Oncol       Date:  2021-06-07       Impact factor: 6.244

6.  LncRNA NEAT1-miR-101-3p/miR-335-5p/miR-374a-3p/miR-628-5p-TRIM6 axis identified as the prognostic biomarker for lung adenocarcinoma via bioinformatics and meta-analysis.

Authors:  Dong-Xiao Ding; Qiao Li; Ke Shi; Hui Li; Qiang Guo; Yun-Qiang Zhang
Journal:  Transl Cancer Res       Date:  2021-11       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.